Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | GI-102 |
Trade Name | |
Synonyms | GI102|GI 102 |
Drug Descriptions |
GI-102 is an immunocytokine comprising a CD80-IgG4-IL2v3 fusion protein, which that potentially induces antitumor immune activity (Journal for ImmunoTherapy of Cancer 2023;11,729; Journal for ImmunoTherapy of Cancer 2023;11,1062). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C200811 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GI-102 | GI-102 | 0 | 1 |